An interventional study of Posterior Capsular Stretching with Dynamic Neuromuscular Stabilization and Posterior Capsular Stretching in Frozen Shoulder, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment
The goal of this **clinical trial** is to determine the effects of posterior capsular stretching with and without Dynamic Neuromuscular Stabilization (DNS) exercises on pain, shoulder internal rotation deficit, disability, and axillary pouch capsule thickness in patients with adhesive capsulitis (frozen shoulder).
The main questions it aims to answer are:
Researchers will compare two groups to determine whether combining DNS exercises with posterior capsular stretching produces greater improvements than posterior capsular stretching alone.
Participants will:
383 studies on the registry are indexed under Bursitis; 111 are open to participants now.
This study's planned enrollment of 40 is close to the median of 44 across 346 interventional studies indexed under Bursitis.
Browse Bursitis studies →University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Both male and female Aged between 40 and 60 years. Diagnosed with FS in the frozen stage (stage 2 and 3) with symptoms persisting for more than three months.
Shoulder pain with NPRS score of 3 to ≤7. Positive glenohumeral Capsular Pattern . No participation in regular structured physical activity programs, physical therapy, or sports activities involving intensive upper-limb use within the past six months.
Exclusion Criteria:
History of surgery involving the upper extremity or trunk within the past year. Presence of acute trauma, inflammation, or other medical conditions affecting the shoulder or upper limb.
Presence of diagnosed cardiovascular, neurological, or psychiatric disorders, contraindicating moderate-intensity physical activity.
Pregnancy at the time of enrollment.
Group A will receive posterior capsular stretching with DNS exercises 4 sessions per week on alternate days for 6 weeks.
Other: Posterior Capsular Stretching with Dynamic Neuromuscular Stabilization
Group B will receive posterior capsular stretching 4 sessions per week on alternate days for 6 weeks.
Other: Posterior Capsular Stretching
Group A will receive posterior capsular stretching with DNS exercises 4 sessions per week on alternate days for 6 weeks.
Group B will receive posterior capsular stretching 4 sessions per week on alternate days for 6 weeks.
Numeric Rating Scale (NPRS)
Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain intensity in low back pain (LBP).The 11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs)
Time frame: Baseline and 6 weeks
MUSCULOSKELETAL ULTRASOUND (AXILLARY POUCH CAPSULE THICKNESS MEASUREMENT)
Musculoskeletal ultrasound has emerged as a valuable imaging modality due to its affordability, portability, absence of ionizing radiation, and capacity for dynamic, real-time assessment at the point of care. The Axillary pouch capsule is the inferior part of the glenohumeral capsule located between the anterior and posterior bands of the inferior glenohumeral ligament (IGHL) The presence of AP thickening will be carefully investigated using the axillary approach and its maximum thickness will be measured with the arm abducted 70 -90 in neutral rotation. The long axis of the transducer will be applied on the axilla along the long axis of the humeral head/neck, then anterior and posterior sliding of the transducer will be done to pick up the maximal obtainable thickening. The axillary pouch thickness will be measured from the humeral neck cortex to the outer margin of the capsule. A high-frequency linear array transducer (7.5-14 MHz) will be used for musculoskeletal assessment. It will
Time frame: Baseline and 6 weeks
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions: pain (5 items) and disability (8 items). Each item is scored on a visual analog scale from 0 to 10, where 0 indicates no pain/no difficulty and 10 indicates worst imaginable pain/so difficult requires help. The total score ranges from 0 to 100, with higher scores indicating greater pain and disability. The SPADI has been shown to have good reliability, validity, and responsiveness in patients with shoulder disorders including adhesive capsulitis
Time frame: Baseline and 6 weeks
INTERNAL ROTATION DEFICIT MESAUREMENT
GIRD defined by a loss of \>20° of IR compared to the contralateral shoulder(23) A difference of 20° or more when compared to the contralateral side is generally considered diagnostic of GIRD.
Time frame: Baseline and 6 weeks
Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: 6 months after the publication of the manuscript.
Access criteria: The data can be requested from the corresponding author.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Management and Technology Lahore